ArticlePharmaceutics2022

Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies.

Abdulsalam Alhalmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.